STOCK TITAN

NASDAQ: FLGT Lawsuit Alert: Investors who lost Money with shares of Fulgent Genetics, Inc. (NASDAQ: FLGT) should contact the Shareholders Foundation

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Very Negative)
Tags

SAN DIEGO, CA / ACCESSWIRE / December 5, 2022 / The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in Fulgent Genetics, Inc. (NASDAQ: FLGT) shares.

Investors who purchased Fulgent Genetics, Inc. (NASDAQ:FLGT) shares in November 2019 or earlier and continue to hold any of their NASDAQ: FLGT shares have also certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

On September 20, 2022, a lawsuit was filed against Fulgent Genetics, Inc. over alleged violations of Securities Laws. The plaintiff alleged that the defendants made false and/or misleading statements and/or failed to disclose that Fulgent Genetics, Inc had been conducting medically unnecessary laboratory testing, engaging in improper billing practices in relation to laboratory testing, and providing or receiving remuneration in violation of the Anti-Kickback Statute and Stark Law, that accordingly, Fulgent Genetics, Inc was likely to become subject to enhanced legal and regulatory scrutiny, that Fulgent's revenues, to the extent they were derived from the foregoing unlawful conduct, were unsustainable, that the foregoing, once revealed, was likely to subject the Company to significant financial and/or reputational harm, and that as a result, the Company's public statements were materially false and misleading at all relevant times.

Those who purchased Fulgent Genetics, Inc. (NASDAQ:FLGT) shares should contact the Shareholders Foundation, Inc.

CONTACT:

Shareholders Foundation, Inc.
Michael Daniels
+1 (858) 779-1554
mail@shareholdersfoundation.com
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108

The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. Any referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is only provided as a public service. It is not intended as legal advice and should not be relied upon.

SOURCE: Shareholders Foundation, Inc.



View source version on accesswire.com:
https://www.accesswire.com/730059/NASDAQ-FLGT-Lawsuit-Alert-Investors-who-lost-Money-with-shares-of-Fulgent-Genetics-Inc-NASDAQ-FLGT-should-contact-the-Shareholders-Foundation

Fulgent Genetics, Inc.

NASDAQ:FLGT

FLGT Rankings

FLGT Latest News

FLGT Stock Data

643.07M
19.89M
32.58%
49.29%
2.02%
Dental Laboratories
Manufacturing
Link
United States of America
EL MONTE

About FLGT

mission developing flexible and affordable genetic testing that improves the everyday lives of those around us. founded in 2011, fulgent began with two simple ideas; flexibility and affordability. today, we strive to create the most effective and wide ranging tests on the market. all of this is done in the pursuit of bettering the everyday lives of our customers. we shine brightest when meaningful relationships, passion, and purpose come together. why fulgent? we are committed to working side-by-side with every one of our clients. this is essential to a strong and successful relationship and is our core way of doing business. we have collaborated with some of the top clinicians in our field who have assisted us in creating our panels, report formatting, and improvements to our website. our approach has always been simple: provide testing based on the specific needs of clinicians and their patients. customer support our support philosophy has always been simple: answer our client's ques